University of Natural Resources and Life Sciences, Vienna (BOKU) - Research portal

Logo BOKU Resarch Portal

Publications

Search Items: AIDS Vaccines - immunology , . hits: 12


** = Publications listed in SCI/SSCI - Journals (published in Web of Science)
* = peer-reviewed publication (not listed in SCI/SSCI)
Only: Full paper/article, Review, Proceedings Paper

2009

** Arnold, GF; Velasco, PK; Holmes, AK; Wrin, T; Geisler, SC; Phung, P; Tian, Y; Resnick, DA; Ma, X; Mariano, TM; Petropoulos, CJ; Taylor, JW; Katinger, H; Arnold, E Broad neutralization of human immunodeficiency virus type 1 (HIV-1) elicited from human rhinoviruses that display the HIV-1 gp41 ELDKWA epitope..

J Virol. 2009; 83(10):5087-5100 WoS PubMed PUBMED Central FullText FullText_BOKU

2008

** Huarte, N; Lorizate, M; Kunert, R; Nieva, JL Lipid modulation of membrane-bound epitope recognition and blocking by HIV-1 neutralizing antibodies..

FEBS Lett. 2008; 582(27):3798-3804 WoS PubMed FullText FullText_BOKU

2005

** Calarese, DA; Lee, HK; Huang, CY; Best, MD; Astronomo, RD; Stanfield, RL; Katinger, H; Burton, DR; Wong, CH; Wilson, IA Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12..

Proc Natl Acad Sci U S A. 2005; 102(38):13372-13377 WoS PubMed PUBMED Central FullText FullText_BOKU

** Haynes, BF; Fleming, J; St Clair, EW; Katinger, H; Stiegler, G; Kunert, R; Robinson, J; Scearce, RM; Plonk, K; Staats, HF; Ortel, TL; Liao, HX; Alam, SM Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies..

Science. 2005; 308(5730):1906-1908 WoS PubMed FullText FullText_BOKU

** Zwick, MB; Jensen, R; Church, S; Wang, M; Stiegler, G; Kunert, R; Katinger, H; Burton, DR Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1..

J Virol. 2005; 79(2):1252-1261 WoS PubMed PUBMED Central FullText FullText_BOKU

2004

** Binley, JM; Wrin, T; Korber, B; Zwick, MB; Wang, M; Chappey, C; Stiegler, G; Kunert, R; Zolla-Pazner, S; Katinger, H; Petropoulos, CJ; Burton, DR Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies..

J Virol. 2004; 78(23):13232-13252 WoS PubMed PUBMED Central FullText FullText_BOKU

2003

** Mascola, JR; Lewis, MG; VanCott, TC; Stiegler, G; Katinger, H; Seaman, M; Beaudry, K; Barouch, DH; Korioth-Schmitz, B; Krivulka, G; Sambor, A; Welcher, B; Douek, DC; Montefiori, DC; Shiver, JW; Poignard, P; Burton, DR; Letvin, NL Cellular immunity elicited by human immunodeficiency virus type 1/ simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodies..

J Virol. 2003; 77(19):10348-10356 WoS PubMed PUBMED Central FullText FullText_BOKU

2001

** Parker, CE; Deterding, LJ; Hager-Braun, C; Binley, JM; Schülke, N; Katinger, H; Moore, JP; Tomer, KB Fine definition of the epitope on the gp41 glycoprotein of human immunodeficiency virus type 1 for the neutralizing monoclonal antibody 2F5..

J Virol. 2001; 75(22):10906-10911 WoS PubMed PUBMED Central FullText FullText_BOKU

** Zwick, MB; Wang, M; Poignard, P; Stiegler, G; Katinger, H; Burton, DR; Parren, PW Neutralization synergy of human immunodeficiency virus type 1 primary isolates by cocktails of broadly neutralizing antibodies..

J Virol. 2001; 75(24):12198-12208 WoS PubMed PUBMED Central FullText FullText_BOKU

1999

** Mascola, JR; Lewis, MG; Stiegler, G; Harris, D; VanCott, TC; Hayes, D; Louder, MK; Brown, CR; Sapan, CV; Frankel, SS; Lu, Y; Robb, ML; Katinger, H; Birx, DL Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies..

J Virol. 1999; 73(5):4009-4018 WoS PubMed PUBMED Central

1998

** Ferko, B; Katinger, D; Grassauer, A; Egorov, A; Romanova, J; Niebler, B; Katinger, H; Muster, T Chimeric influenza virus replicating predominantly in the murine upper respiratory tract induces local immune responses against human immunodeficiency virus type 1 in the genital tract..

J Infect Dis. 1998; 178(5):1359-1368 WoS PubMed

1995

** Muster, T; Ferko, B; Klima, A; Purtscher, M; Trkola, A; Schulz, P; Grassauer, A; Engelhardt, OG; García-Sástre, A; Palese, P Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus..

J Virol. 1995; 69(11):6678-6686 WoS PubMed PUBMED Central FullText

↑ Top of page / Navigation

↑ Top of page / Navigation

© BOKU Wien • Imprint